| Structure |
Chemical Name |
CAS |
MF |
 |
DexMedetoMidine IMpurity 15 |
|
|
 |
LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl) |
1933471-30-7 |
C8H14N2O3 |
 |
Pabuxilibu impurities |
3079368-27-4 |
|
 |
Argon-Nitrogen mixture |
|
|
![(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- methoxyphenyl)piperidine-1-carboxylate](/CAS/20200331/GIF/CB55495356.gif) |
(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- methoxyphenyl)piperidine-1-carboxylate |
|
C27H27NO6 |
 |
Anagrelide impurity 4 |
1092352-99-2 |
C10H6Cl3N3O |
 |
Labetalol IMpurity B |
802620-01-5 |
C20H25NO4 |
 |
Cabozantinib Impurity A |
|
|
![2-(2-ethoxy-3-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one](/) |
2-(2-ethoxy-3-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one |
|
|
 |
Carfilzomib Impurity 4 |
|
|
 |
Aprepitant iMpurity 38 |
|
|
 |
(S)-N-Didemethyl Dapoxetine |
147199-40-4 |
C19H19NO |
 |
Aprepitant Impurity 22 |
934540-48-4 |
C20H16F7NO2 |
 |
Gadobutrol Impurity 3 |
2227984-48-5 |
|
 |
Apremilast Impurity D |
|
|
![(2S)-Pinocembrin 7-O-[2''-O-(5'''-O-trans
-cinnamoyl)-β-D-apiofuranosyl]-β-D-glucoside](/CAS/20210111/GIF/773899-29-9.gif) |
(2S)-Pinocembrin 7-O-[2''-O-(5'''-O-trans
-cinnamoyl)-β-D-apiofuranosyl]-β-D-glucoside |
773899-29-9 |
C35H36O14 |
 |
Peramivir Chlorinated Impurity |
|
|
 |
EP Impurity Catalog |
|
|
 |
Cefazolin Impurity C (EP) |
|
|
 |
Timolol maleate impurity 02 |
|
|
![sodium 5-methoxy-2-sulfinatobenzo[d]imidazol-1-id](/) |
sodium 5-methoxy-2-sulfinatobenzo[d]imidazol-1-id |
|
|
 |
Oseltamivir Impurity 101 |
|
|
 |
Teneligliptin Impurity 3 |
|
|
 |
クエチアピンヒドロキシ不純物 |
329216-67-3 |
C19H21N3OS |
 |
1',15-オキシエリスロマイシン |
41451-91-6 |
C37H65NO14 |
 |
3-ニトロ-1-エチニルベンゼン |
3034-94-4 |
C8H5NO2 |
![(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid](/CAS/20150408/GIF/1039307-95-3.gif) |
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoic acid |
1039307-95-3 |
C18H21NO2 |
 |
Olsalazine Impurity F |
|
|
 |
MetaMizole IMpurity C (4-MethylaMinoantipyrine) HCl |
856307-27-2 |
C12H16ClN3O |
 |
Cefradine Impurity 8 |
30959-67-2 |
C16H19N3O4S |
 |
Bortezomib Impurity 16 |
|
|
 |
6-methyl-2-oxo-5-pyridin-2-yl-1H-pyridine-3-carbonitrile |
106637-42-7 |
C12H9N3O |
 |
3,5,3',5'-TETRAIODO THYROLACTIC ACID |
7069-47-8 |
C15H10I4O5 |
 |
Cabozantinib impurity 40 |
|
|
 |
Fasudil Impurity 6 |
1581642-06-9 |
C14H18ClN3O2S |
![IMp. A (EP) as Hydrochloride: 3-[[[2-[(DiaMinoMethylene)aMino]thiazol-4-yl]- Methyl]sulphanyl]propaniMidaMide Hydrochloride](/) |
IMp. A (EP) as Hydrochloride: 3-[[[2-[(DiaMinoMethylene)aMino]thiazol-4-yl]- Methyl]sulphanyl]propaniMidaMide Hydrochloride |
|
|
 |
Brimonidine Impurity D |
|
|
 |
LaMotrigine IMpurity |
|
|
 |
Clopidogrel |
1360923-54-1 |
C16H16ClNO3S |
 |
Rivaroxaban Impurity 24 |
|
|
 |
Peramivir Impurity 22 |
|
|
 |
(trans)-4-((2-amino-4,6-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
 |
Alogliptin iMpurity |
60271-06-9 |
C7H10N2O3 |
 |
Febuxostat Impurity 97 |
|
|
 |
147027-08-5 |
147027-08-5 |
C14H24O4S |
![(2S,3R)-2-[(1S)-1-[3,5-ビス(トリフルオロメチル)フェニル]エトキシ]-3-(4-フルオロフェニル)モルホリン](/CAS/20150408/GIF/327623-37-0.gif) |
(2S,3R)-2-[(1S)-1-[3,5-ビス(トリフルオロメチル)フェニル]エトキシ]-3-(4-フルオロフェニル)モルホリン |
327623-37-0 |
C20H18F7NO2 |
 |
2H-1,3-ベンゾジオキソール-4-オール |
69393-72-2 |
C7H6O3 |
 |
AtracuriuM IMpurity C1 (trans-Monoacrylate) |
|
|
 |
Pidotimod Impurity O |
|
|
 |
Palbociclib Impurity 1 |
|
|
 |
2-メトキシ-5-スルホ安息香酸1-メチル |
94134-07-3 |
C9H10O6S |
 |
シュードモン酸Dナトリウム |
85178-60-5 |
C26H41NaO9 |
 |
krypton-78 |
33580-79-9 |
Kr |
 |
Fluconazole IMpurity I |
|
C13H12F2N6O |
 |
Cefminox Impurity 5 |
|
|
![2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1,1'-dioxide](/CAS/20210305/GIF/2724840-93-9.gif) |
2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1,1'-dioxide |
2724840-93-9 |
C18H15ClN2O4S |
 |
Indacaterol Impurity 7 |
1403389-05-8 |
C24H30N2O3 |
 |
(17α)-4-Bromo-17-hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile |
98149-13-4 |
C20H24BrNO2 |
 |
Pitavastatin Impurity 72 |
|
|
![5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide](/CAS/GIF/325855-74-1.gif) |
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide |
325855-74-1 |
C18H15ClN2O3S |
 |
2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide hydrochloride |
1640971-87-4 |
C10H18ClN3O |
![(1α,2β,4β,5α)-9-メチル-3-オキサ-9-アザトリシクロ[3.3.1.02,4]ノナン-7α-オール](/CAS/20180808/GIF/498-46-4.gif) |
(1α,2β,4β,5α)-9-メチル-3-オキサ-9-アザトリシクロ[3.3.1.02,4]ノナン-7α-オール |
498-46-4 |
C8H13NO2 |
![N-[(10S)-3,4,5,14-テトラメトキシ-13-オキソトリシクロ[9.5.0.02,7]ヘキサデカ-1(16),2(7),3,5,11,14-ヘキサエン-10-イル]ホルムアミド](/CAS/GIF/7411-12-3.gif) |
N-[(10S)-3,4,5,14-テトラメトキシ-13-オキソトリシクロ[9.5.0.02,7]ヘキサデカ-1(16),2(7),3,5,11,14-ヘキサエン-10-イル]ホルムアミド |
7411-12-3 |
C21H23NO6 |
 |
6-Hydroxy Nicorandil |
113743-17-2 |
C8H9N3O5 |
 |
Cefazolin USP Impurity L-△2 |
|
|
 |
3-Formyl-25-desacetyl Rifamycin |
16783-97-4 |
C36H45NO12 |
 |
Ropivacaine-cycle |
1945965-95-6 |
C17H24N2O |
 |
(R)-diethyl 2-(4-(3-chloro-4-fluorophenylaMino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-ylaMino)-2-oxo |
618061-77-1 |
C24H27ClFN4O6P |
 |
Canagliflozin Impurity 16 |
|
|
![ForMaMide, N-[5-(2R)-oxiranyl-2-(phenylMethoxy)phenyl]-](/CAS/GIF/201677-57-8.gif) |
ForMaMide, N-[5-(2R)-oxiranyl-2-(phenylMethoxy)phenyl]- |
201677-57-8 |
C16H15NO3 |
 |
13-Cis Vitamin A Palmitate |
26771-20-0 |
C36H60O2 |
 |
Pazopanib Related Compound 2 |
1226500-02-2 |
C26H23ClN10 |
 |
Ticagrelor Imp.J |
2248538-63-6 |
C14H20ClN5O4S |
 |
AtracuriuM IMpurity I (Mixture of cis, trans(I1), cis, cis(I2), tans, trans IsoMer) |
|
|
 |
N-((4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl) sulfonyl)acetamide |
198471-47-5 |
C19H16F3N3O3S |
 |
Atracurium Impurity 25 |
86682-55-5 |
C20H25NO5 |
![2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one](/CAS/GIF/197010-20-1.gif) |
2-[(1-Benzylpiperidin-4-yl)hydroxyMethyl]-5,6-diMethoxyindan-1-one |
197010-20-1 |
C24H29NO4 |
 |
8-Dechloro-9-chloro Loratadine |
109537-11-3 |
C22H23ClN2O2 |
 |
N-Desmethyl Citalopram-d4 Oxalate |
62498-68-4 |
C21H21FN2O5 |
 |
(S)-4-(4-Hydrazinobenzyl)-2-oxazolidinone Hydrochloride |
139264-57-6 |
C10H13N3O2.ClH |
 |
Ranitidine impurity F |
|
C13H22N4O3S |
![(1R,5S,6R)-REL-5-(1-エチルプロポキシ)-7-オキサビシクロ[4.1.0]ヘプト-3-エン-3-カルボン酸エチルエステル](/CAS/GIF/347378-74-9.gif) |
(1R,5S,6R)-REL-5-(1-エチルプロポキシ)-7-オキサビシクロ[4.1.0]ヘプト-3-エン-3-カルボン酸エチルエステル |
347378-74-9 |
C14H22O4 |
 |
2,4,6-トリプロピル-1,3,5-トリオキサン |
2396-43-2 |
C12H24O3 |
 |
Bimatoprost Impurity 22 |
|
|
![N-formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide](/CAS/20180703/GIF/1351611-14-7.gif) |
N-formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
1351611-14-7 |
C26H25N5O5 |
![α,α''-[(Methylimino)di-2,1-ethanediyl]bis-benzenemethanol](/CAS/20240320/GIF/857786-66-4.gif) |
α,α''-[(Methylimino)di-2,1-ethanediyl]bis-benzenemethanol |
857786-66-4 |
C19H25NO2 |
![Hexanamide, N-[(1S)-1-(aminocarbonyl)propyl]-3-(hydroxymethyl)-, (3R)-](/CAS/20210305/GIF/2252417-17-5.gif) |
Hexanamide, N-[(1S)-1-(aminocarbonyl)propyl]-3-(hydroxymethyl)-, (3R)- |
2252417-17-5 |
C11H22N2O3 |
 |
Brexpiprazole Impurity 34 |
2247155-42-4 |
C25H27N3O4S |
 |
Milrinone IMpurity 3 |
98293-81-3 |
C12H7N3O3 |
 |
Fudosteine Impurity 2 |
1480319-53-6 |
C6H13NO5S |
 |
benzbroMarone iMpurity |
|
|
 |
N-(2-Chloro-ethyl)-N'-(2,3-dichloro-phenyl)-ethane-1,2-diamine |
|
C10H13Cl3N2 |
 |
Ticagrelor Impurity 125 |
|
|
 |
PD 312237 |
501666-23-5 |
C20H35NO11 |
 |
Brivaracetam Impurity 56 |
|
|
 |
Tofacitinib Impurity I |
|
|
 |
デフェラシロックスサリチロイルエステル |
1395346-28-7 |
C28H19N3O6 |
 |
Salbutamol Impurity 37 |
|
|
 |
((2R,3R,4R)-3-(benzoyloxy)-4-chloro-4-Methyl-5-oxotetrahydrofuran-2-yl)Methyl benzoate |
1496551-65-5 |
C20H17ClO6 |
 |
Apremilast Impurity C |
|
|